Results 121 to 130 of about 4,951 (172)
Some of the next articles are maybe not open access.
Tonin and Kallikrein-Kinin System
1989The kininogenase activity of tonin has been demonstrated by Ikeda and Arakawa, 1984. Tonin of the rat submandibular gland contracts the rat uterus independent of addition of the substrate. On repetition, the same dose of enzyme elicited desensitization. When a double dose was used the contraction again occurred.
M H, Feitosa +5 more
openaire +2 more sources
The Kallikrein-Kinin System in Inflammation
1989The kallikrein kinin system is shown diagrammatically in Figure 1 and indicates the various pathways by which kinin (bradykinin or lysyl bradykinin) can be formed. The intrinsic coagulation-kinin system is depicted on the left, and the tissue kallikrein-kinin pathway on the right.
A P, Kaplan +4 more
openaire +2 more sources
Plasma Kallikrein-Kinin System in Septicemia
Archives of Surgery, 1983Plasma prekallikrein and functional kallikrein inhibition were studied in 18 surgical patients with complicating septicemia using chromogenic peptide substrate assays. Nine patients died and nine survived. In all 18 patients plasma prekallikrein values were reduced markedly when septicemia was diagnosed.
A O, Aasen +2 more
openaire +2 more sources
The Kallikrein-Kinin System in the Kidney
2015To understand the role of the kallikrein-kinin system in the kidney all components of the system and their localization need to be considered. About half the kallikrein in urine occurs as the proenzyme which arises in the distal tubule. Kinins are formed in the distal tubule and collecting duct from urokinnogen which is found throughout the tubule ...
J J, Pisano +3 more
openaire +2 more sources
The Kallikrein–Kinin System In Humans
Clinical and Experimental Pharmacology and Physiology, 2001SUMMARY1. Kinin peptides are implicated in many physiological and pathological processes, including the regulation of blood pressure and sodium homeostasis, inflammation and the cardioprotective effects of preconditioning. In humans, the plasma and tissue kallikrein–kinin systems (KKS) generate bradykinin and kallidin peptides, respectively.2.
openaire +2 more sources
The Kallikrein-Kinin System and the Kidney
Annual Review of Physiology, 1984Kallikrein (E.C. 3.4.21.8) was first found in mammalian urine more than 70 years ago (I). This urinary enzyme is now known to be synthesized in the kidney, to have biochemical actions and structural features similar to several other mammalian proteinases, and to be regulated by hormones that control important aspects of renal function.
openaire +2 more sources
The development of insulitis and the kallikrein–kinin system
International Immunopharmacology, 2002Data derived from animals and humans suggest that the onset of diabetes is associated with hemodynamic changes in the renal circulation leading to increased renal plasma flow (RPF), glomerular capillary hyperfusion, and an increased glomerular transcapillary hydraulic pressure gradient.
Adriana, Zucollo +4 more
openaire +2 more sources
Components of the Kallikrein-Kinin System in Urine
1979The excretion of kallikrein in urine varies, but the pathophysiologic implications are not clear. To help clarify the role of the urinary kallikrein-kinin system, we have begun to define components of the system as they occur in urine. To minimize artifacts which may arise through extensive purification procedures, we studied urinary protein ...
J W, Ryan +3 more
openaire +2 more sources
Kallikrein-Kinins in the Central Nervous System
Clinical and Experimental Hypertension. Part A: Theory and Practice, 1984We studied whether the components of the kallikrein-kinin system are present in the central nervous system. We found that human cerebrospinal fluid (CSF) contains free kinins: 53 +/- 15 pg/ml; kininogen: 10.9 +/- 2.1 ng kinin equivalent/ml, and kininogenase activity: 5.0 +/- 2.1 ng kinins/ml/minute.
A G, Scicli +4 more
openaire +2 more sources
The Kallikrein-Kinin System in Diabetic Retinopathy
2014Diabetic retinopathy (DR) is a major microvascular complication associated with type 1 and type 2 diabetes mellitus, which can lead to visual impairment and blindness. Current treatment strategies for DR are mostly limited to laser therapies, steroids, and anti-VEGF agents, which are often associated with unwanted side effects leading to further ...
Menakshi, Bhat +3 more
openaire +2 more sources